Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 14 | 95116680 | stop gained | G/A | snv |
|
Neoplasms | 0.700 | 1.000 | 4 | 2013 | 2016 | ||||||||
|
0.925 | 0.080 | 14 | 95103856 | stop gained | G/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 2009 | 2016 | ||||||||
|
1.000 | 0.040 | 14 | 95116575 | stop gained | G/A | snv |
|
Neoplasms | 0.700 | 1.000 | 3 | 2009 | 2015 | ||||||||
|
1.000 | 0.040 | 14 | 95113166 | stop gained | G/A;C | snv | 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 3 | 2009 | 2011 | |||||||
|
1.000 | 0.040 | 14 | 95124195 | splice donor variant | C/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 3 | 2009 | 2014 | ||||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||||
|
1.000 | 0.040 | 14 | 95108095 | splice acceptor variant | T/C | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
1.000 | 0.040 | 14 | 95105784 | splice acceptor variant | C/A | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
1.000 | 0.040 | 14 | 95106040 | splice donor variant | C/T | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
1.000 | 0.040 | 14 | 95116696 | splice acceptor variant | C/T | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
1.000 | 0.040 | 14 | 95124669 | splice acceptor variant | C/G | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
0.662 | 0.640 | 14 | 95087025 | 3 prime UTR variant | A/G | snv | 8.7E-02 |
|
Infections | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.662 | 0.640 | 14 | 95087025 | 3 prime UTR variant | A/G | snv | 8.7E-02 |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||||
|
1.000 | 0.040 | 14 | 95115704 | stop gained | G/A;C | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||||
|
1.000 | 0.040 | 14 | 95099779 | splice donor variant | C/A;G | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
1.000 | 0.040 | 14 | 95116680 | stop gained | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 2 | 2013 | 2014 | ||||||||
|
1.000 | 0.040 | 14 | 95113091 | splice donor variant | C/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 2 | 2011 | 2014 | ||||||||
|
0.925 | 0.080 | 14 | 95103856 | stop gained | G/T | snv |
|
Neoplasms | 0.700 | 1.000 | 2 | 2009 | 2015 | ||||||||
|
1.000 | 0.040 | 14 | 95090065 | 3 prime UTR variant | C/A | snv | 2.9E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.440 | 14 | 95087805 | 3 prime UTR variant | T/C | snv | 0.26 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 |